Two more COVID-19 vaccines recognised by Australia as preventing virus spread

Students vaccinated with the Covaxin and BBIBP-Corv vaccines are now able to enter Australia as soon as restrictions are lifted.

11 Nov 2021

Students vaccinated with the Covaxin and BBIBP-Corv vaccines are now able to enter Australia as soon as restrictions are lifted. 

Australia’s Therapeutic Goods Administration (TGA) has determined the India-produced Covaxin and Chinese-manufactured BBIBP-CorV vaccines not only protect the vaccinated person but potentially reduce the likelihood of COVID-19 transmission.

The announcement will have significant impacts for the return of students and citizens of China and India as well as countries in the region who have used these vaccines to protect their citizens from COVID-19 AND whose citizens would like to visit Australia.

The two vaccines join Sinovac, Covishield and Janssen vaccines as ones officially recognised by Australia administered to people outside Australia, along with Pfizer and AstraZeneca (both of which are also administered to students and Australian citizens inside Australia).

Those who have received two doses of a vaccine at least 14 days apart are considered fully vaccinated 7 days after the second dose (or in the case of the single dose Janssen vaccine, 7 days after the dose).

Read more about the TGA announcement here.